Epidiolex Growth Fuels GW Pharma Revenue Above Expectations to $120.6 Million

New Cannabis Ventures
By NCV NewswireMay 11, 2020, 4:25 pm288 pts
GW Pharmaceuticals plc Reports First Quarter 2020 Financial Results and Operational Progress – Total revenue of $120.6 million – – Total Epidiolex® net product sales of $116.1 million – – Conference call today at 4:30 p.m. EDT – LONDON and CARLSBAD, Calif., May 11, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Cannabis MSO Trulieve escapes ‘debt tsunami’ with $368 million payoff 78

Virginia voters signal adult-use cannabis market launch, but bans pass elsewhere 77

Virginia Gov.-Elect Abigail Spanberger Supports Adult-Use Cannabis Sales 77

Nebraska AG ‘Retaliating’ Against Omaha Tribe for Medical Cannabis Plans 74

Virginia election signals biggest opportunity in years for adult-use cannabis industry 72

Marijuana Arrests Are The Primary Driver Of The War On Drugs In States That Still Criminalize It, FBI Data Shows 72

Sudden changes threaten to disrupt Minnesota’s hemp THC market 71

Trulieve Q3 Revenue Rises 1% 70

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.